There are now over 1.1 million Australians living with a diagnosis of cancer. Consistent with the Quadruple Aim - a value-based health care strategy that seeks to (1) improve the patient experience; (2) improve the health of populations; (3) reduce the cost of care; and (4) improve the provider experience, clinical and research leaders must continue to provide care, self-care and caring solutions that address these important goals for all cancer survivors and the community.
Following on from the American Institute of Medicine Report “Lost in Transition”, various frameworks have advocated for a number of quality survivorship domains of care activities and outcomes. There are a number of ways to test and evaluate outcomes of innovations in follow-up care models. However, there is less evidence and consensus in terms of what constitute “value” in these evaluative endeavours. This presentation will describe a range of methodologies including hybrid effectiveness-implementation trials, qualitative research and discrete choice experiments, and how they have been used to investigate preferences for and the value of survivorship care models.